Literature DB >> 22327868

[Gemcitabine in the chemoradiotherapy for locally advanced pancreatic cancer: a meta-analysis].

T Brunner1.   

Abstract

Entities:  

Year:  2012        PMID： 22327868     DOI： 10.1007/s00066-012-0079-2

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN： 0179-7158            Impact factor:   3.621


× No keyword cloud information.
  4 in total

Review 1.  Pancreatic cancer.

Authors:  Manuel Hidalgo
Journal:  N Engl J Med       Date:  2010-04-29       Impact factor: 91.245

2.  Volumetric modulated arc therapy for advanced pancreatic cancer.

Authors:  Wietse Eppinga; Frank Lagerwaard; Wilko Verbakel; Ben Slotman; Suresh Senan
Journal:  Strahlenther Onkol       Date:  2010-06-24       Impact factor: 3.621

3.  Gemcitabine alone versus gemcitabine plus radiotherapy in patients with locally advanced pancreatic cancer: an Eastern Cooperative Oncology Group trial.

Authors:  Patrick J Loehrer; Yang Feng; Higinia Cardenes; Lynne Wagner; Joanna M Brell; David Cella; Patrick Flynn; Ramesh K Ramanathan; Christopher H Crane; Steven R Alberts; Al B Benson
Journal:  J Clin Oncol       Date:  2011-10-03       Impact factor: 44.544

Review 4.  Neoadjuvant therapy for resectable pancreatic cancer.

Authors:  Chandrajit P Raut; Douglas B Evans; Christopher H Crane; Peter W T Pisters; Robert A Wolff
Journal:  Surg Oncol Clin N Am       Date:  2004-10       Impact factor: 3.495
  4 in total
  5 in total

Review 1.  Essential role of radiation therapy for the treatment of pancreatic cancer : Novel study concepts and established treatment recommendations.

Authors:  Sophie Dobiasch; Nicole L Goerig; Rainer Fietkau; Stephanie E Combs
Journal:  Strahlenther Onkol       Date:  2017-11-01       Impact factor: 3.621

2.  Outcome after neoadjuvant chemoradiation and correlation with nutritional status in patients with locally advanced pancreatic cancer.

Authors:  P Naumann; D Habermehl; T Welzel; J Debus; S E Combs
Journal:  Strahlenther Onkol       Date:  2013-07-31       Impact factor: 3.621

3.  α-Mangostin suppresses human gastric adenocarcinoma cells in vitro via blockade of Stat3 signaling pathway.

Authors:  Tao Shan; Xi-juan Cui; Wei Li; Wan-run Lin; Hong-wei Lu; Yi-ming Li; Xi Chen; Tao Wu
Journal:  Acta Pharmacol Sin       Date:  2014-06-30       Impact factor: 6.150

4.  α-Mangostin suppresses lipopolysaccharide-induced invasion by inhibiting matrix metalloproteinase-2/9 and increasing E-cadherin expression through extracellular signal-regulated kinase signaling in pancreatic cancer cells.

Authors:  Jiangtao Yuan; Yaolu Wu; Guifang Lu
Journal:  Oncol Lett       Date:  2013-04-04       Impact factor: 2.967

5.  Sulforaphane enhances irradiation effects in terms of perturbed cell cycle progression and increased DNA damage in pancreatic cancer cells.

Authors:  Patrick Naumann; Jakob Liermann; Franco Fortunato; Thomas E Schmid; Klaus-Josef Weber; Jürgen Debus; Stephanie E Combs
Journal:  PLoS One       Date:  2017-07-10       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.